1. Home
  2. Analysis
  3. Methocarbamol
  4. Electrolyte-imbalance

Methocarbamol and Electrolyte imbalance - a phase IV clinical study of FDA data

Summary:

Electrolyte imbalance is reported as a side effect among people who take Methocarbamol (methocarbamol), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Ambien, and have Osteoporosis.

The phase IV clinical study analyzes which people have Electrolyte imbalance when taking Methocarbamol. It is created by eHealthMe based on reports of 16,788 people who have side effects when taking Methocarbamol from the FDA, and is updated regularly.

What is Methocarbamol?

Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.

What is Electrolyte imbalance?

Electrolyte imbalance is found to be associated with 1,083 drugs and 1,219 conditions by eHealthMe. Check the latest studies of Electrolyte imbalance.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

16,788 people reported to have side effects when taking Methocarbamol.
Among them, 24 people (0.14%) have Electrolyte imbalance.

Could Methocarbamol cause Electrolyte imbalance?

Among these 24 people:

How long have people been on Methocarbamol when they have Electrolyte imbalance? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Electrolyte imbalance when taking Methocarbamol? *

  • female: 79.17 %
  • male: 20.83 %

What is the age of people who have Electrolyte imbalance when taking Methocarbamol? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 15.79 %
  • 40-49: 10.53 %
  • 50-59: 10.53 %
  • 60+: 63.16 %

What are other drugs people take besides Methocarbamol? *

  1. Ambien: 10 people, 41.67%
  2. Fosamax: 9 people, 37.50%
  3. Maxzide: 8 people, 33.33%
  4. Timolol: 8 people, 33.33%
  5. Zoloft: 8 people, 33.33%
  6. Aciphex: 8 people, 33.33%
  7. Levoxyl: 8 people, 33.33%
  8. Premarin: 8 people, 33.33%
  9. Atenolol: 8 people, 33.33%
  10. Xyrem: 7 people, 29.17%

What are other side effects people have besides Electrolyte imbalance? *

  1. Urinary Tract Infection: 12 people, 50.00%
  2. Nausea And Vomiting: 10 people, 41.67%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 10 people, 41.67%
  4. Chest Pain: 10 people, 41.67%
  5. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 10 people, 41.67%
  6. Swallowing Difficulty: 10 people, 41.67%
  7. Weakness: 10 people, 41.67%
  8. Nausea (feeling of having an urge to vomit): 9 people, 37.50%
  9. Hypovolaemia (a decreased volume of circulating blood in the body): 9 people, 37.50%
  10. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 9 people, 37.50%

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 8 people, 33.33%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 29.17%
  3. Cystic Fibrosis (disease of the secretary glands): 2 people, 8.33%
  4. Urinary Tract Infection: 1 person, 4.17%
  5. Type 2 Diabetes: 1 person, 4.17%
  6. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 1 person, 4.17%
  7. Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 1 person, 4.17%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 4.17%
  9. Confusional State: 1 person, 4.17%
  10. Belching (release of gas from the digestive tract): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Methocarbamol and have Electrolyte imbalance?

- Check whether Electrolyte imbalance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methocarbamol:

Electrolyte imbalance treatments and more:

How severe was Electrolyte imbalance and when was it recovered:

Expand to all the drugs that have ingredients of methocarbamol:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methocarbamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrolyte imbalance:

Browse all the conditions that are associated with Electrolyte imbalance:

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Methocarbamol) and Methocarbamol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.